UK markets open in 3 hours 17 minutes
  • NIKKEI 225

    +39.97 (+0.13%)

    +42.97 (+0.15%)

    -0.02 (-0.03%)

    -4.00 (-0.23%)
  • DOW

    +305.10 (+0.90%)

    -22.99 (-0.05%)
  • CMC Crypto 200

    +19.33 (+1.40%)
  • ^IXIC

    +180.92 (+1.31%)
  • ^FTAS

    +24.05 (+0.61%)

Worldwide Fill Finish Manufacturing Industry to 2027 - Rising Adoption of Prefilled Syringes for Parenteral Administration is Driving Growth

Research and Markets
·9-min read

Dublin, March 31, 2021 (GLOBE NEWSWIRE) -- The "Fill Finish Manufacturing Market Forecast to 2027 - COVID-19 Impact and Analysis - by Product and End User, and Geography" report has been added to's offering.

According to this report the global fill finish manufacturing market is expected to reach US$ 12,547.23 million by 2027 from US$ 6,129.03 million in 2019. The market is estimated to grow at a CAGR of 9.6 % from 2020 to 2027. The report highlights trends prevailing in the market, and drivers and hindrances pertaining to the market growth.

Based on products, the fill finish manufacturing market is segmented into consumables and instruments. The consumables is further segmented into prefilled syringes, vials, cartridges, and other consumables. In 2019, the consumables segment accounted for a larger share of the market and is expected to register a higher CAGR during the forecast period. Growth of this segment is attributed to high replacement rate compared with that of instruments, rising adoption of prefilled syringes, wide applications of vials in lyophilization, and increasing fill-finish outsourcing.

Based on end user, the fill finish manufacturing market is segmented into contract manufacturing organizations, biopharmaceutical companies, and other end users. The contract manufacturing organizations segment held the largest share of the market in 2019 and is anticipated to register the highest CAGR in the market during the forecast period.

COVID-19 pandemic has become the most significant challenge across the world. However, the pandemic has brought several growth opportunities to the pharmaceutical and biopharmaceutical companies to strengthen their R&D for vaccine formulation against the coronavirus. Moderna, Inc. and Catalent, Inc. announced a collaboration for large-scale, commercial fill-finish manufacturing of Moderna's mRNA-based COVID-19 vaccine candidate (mRNA-1273) at Catalent's biologics facility in Bloomington.

On December 9, 2020, CureVac N.V, a global clinical-stage biopharmaceutical company developed a new class of transformative medicines based on messenger ribonucleic acid (mRNA), and Fareva announced an agreement regarding the fill & finish manufacturing of CureVac's COVID-19 vaccine candidate, CVnCoV, at Fareva's Pau and Val-de-Reuil-sites in France. Wockhardt Ltd has entered into an agreement with the UK government to fill and finish COVID-19 vaccine vials at its subsidiary CP Pharmaceuticals' facility based in Wrexham, North Wales. Thus, such collaborations are expected to show a positive impact on the fill-finish manufacturing market in the coming few years.

Becton, Dickinson and Company (BD), West Pharmaceutical Services, Gerresheimer, Robert Bosch (Syntegon Technology GmbH), IMA, Optima, Bausch + Strobel, Groninger, Maquinaria Industrial Dara, NIPRO PharmPackaging, SCHOTT AG, SGD Pharma, and Stevanato Group are among the leading companies operating in the fill finish manufacturing market.

Reasons to Buy

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Fill Finish Manufacturing market.

  • Highlights key business priorities in order to assist companies to realign their business strategies.

  • The key findings and recommendations highlight crucial progressive industry trends in the global Fill Finish Manufacturing market, thereby allowing players across the value chain to develop effective long-term strategies.

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Key Topics Covered:

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Fill Finish Manufacturing Market- By Product
1.3.2 Global Fill Finish Manufacturing Market- By End User
1.3.3 Global Fill Finish Manufacturing Market- By Geography

2. Fill Finish Manufacturing Market- Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Global Fill Finish Manufacturing Market- Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 APAC PEST Analysis
4.2.4 SCAM PEST Analysis
4.2.5 MEA PEST Analysis
4.3 Expert Opinion

5. Fill Finish Manufacturing Market- Industry Dynamics
5.1 Market Drivers
5.1.1 Rising Adoption of Prefilled Syringes for Parenteral Administration
5.1.2 Elevating Demand for Biologics
5.2 Market Restraints
5.2.1 Growing Competition in Biopharmaceutical Contract Manufacturing Industry
5.3 Market Opportunities
5.3.1 Low Business Costs in Emerging Markets
5.4 Future Trends
5.4.1 Single-Use Systems for Aseptic Fill Finish
5.5 Impact Analysis

6. Fill Finish Manufacturing Market- Global Analysis
6.1 Global Fill Finish Manufacturing Market Revenue Forecast and Analysis
6.2 Global Fill Finish Manufacturing Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players

7. Fill Finish Manufacturing Market Analysis- by Product
7.1 Overview
7.2 Fill Finish Manufacturing Market Share, by Product, 2019 & 2027 (%)
7.3 Consumables
7.3.1 Overview
7.3.2 Consumables Market Revenue and Forecasts to 2027 (US$ Million)
7.3.3 Prefilled Syringes Overview Prefilled Syringes: Fill Finish Manufacturing Market- Revenue and Forecast to 2027 (US$ Million)
7.3.4 Vials Overview Vials: Fill Finish Manufacturing Market- Revenue and Forecast to 2027 (US$ Million)
7.3.5 Cartridges Overview Cartridges: Fill Finish Manufacturing Market- Revenue and Forecast to 2027 (US$ Million)
7.3.6 Other Consumables Overview Other Consumables: Fill Finish Manufacturing Market- Revenue and Forecast to 2027 (US$ Million)
7.4 Instruments
7.4.1 Overview
7.4.2 Instruments Market Revenue and Forecasts to 2027 (US$ Million)

8. Fill Finish Manufacturing Market Analysis- by End-User
8.1 Overview
8.2 Fill Finish Manufacturing Market Share, by End-User, 2019 & 2027 (%)
8.3 Biopharmaceutical Companies
8.3.1 Overview
8.3.2 Biopharmaceutical Companies Market Revenue and Forecasts to 2027 (US$ Million)
8.4 Contract Manufacturing Organizations
8.4.1 Overview
8.4.2 Contract Manufacturing Organizations Market Revenue and Forecasts to 2027 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others Market Revenue and Forecasts to 2027 (US$ Million)

9. Fill Finish Manufacturing Market - Geographic Analysis
9.1 North America: Fill Finish Manufacturing Market
9.2 Europe: Fill Finish Manufacturing Market
9.3 Asia Pacific: Fill Finish Manufacturing Market
9.4 Middle East & Africa: Fill Finish Manufacturing Market
9.5 South and Central America: Fill Finish Manufacturing Market

10. Impact Of COVID-19 Pandemic on Global Fill Finish Manufacturing Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
10.2 Europe: Impact Assessment of COVID-19 Pandemic
10.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
10.4 Rest of the World: Impact Assessment of COVID-19 Pandemic

11. Industry Landscape
11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.4 Organic Developments
11.4.1 Overview
11.5 Inorganic Developments
11.5.1 Overview

12. Company Profiles
12.1 BD
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 West Pharmaceutical Services, Inc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Gerresheimer AG
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 I.M.A. Industria Macchine Automatiche S.p.A.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Optima Packaging Group Gmbh
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Bausch+Strobel
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Groninger and Co. GmbH
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Maquinaria Industrial Dara SL
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Nipro PharmaPackaging
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
12.11 SGD Pharma
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments
12.12 Stevanato Group SpA
12.12.1 Key Facts
12.12.2 Business Description
12.12.3 Products and Services
12.12.4 Financial Overview
12.12.5 SWOT Analysis
12.12.6 Key Developments
12.13 Syntegon Technology GmbH (Bosch Packaging Technology)
12.13.1 Key Facts
12.13.2 Business Description
12.13.3 Products and Services
12.13.4 Financial Overview
12.13.5 SWOT Analysis
12.13.6 Key Developments

13. Appendix
13.1 About the Publisher
13.2 Glossary of Terms

For more information about this report visit

CONTACT: CONTACT: Laura Wood, Senior Press Manager For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900